Cargando…
Cytoplasmic Cyclin E Is an Independent Marker of Aggressive Tumor Biology and Breast Cancer-Specific Mortality in Women over 70 Years of Age
Multi-cohort analysis demonstrated that cytoplasmic cyclin E expression in primary breast tumors predicts aggressive disease. However, compared to their younger counterparts, older patients have favorable tumor biology and are less likely to die of breast cancer. Biomarkers therefore require interpr...
Autores principales: | Johnston, Simon J., Syed, Binafsha M., Parks, Ruth M., Monteiro, Cíntia J., Caruso, Joseph A., Green, Andrew R., Ellis, Ian O., Hunt, Kelly K., Karakas, Cansu, Keyomarsi, Khandan, Cheung, Kwok-Leung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7140020/ https://www.ncbi.nlm.nih.gov/pubmed/32197318 http://dx.doi.org/10.3390/cancers12030712 |
Ejemplares similares
-
Cyclin E overexpression as a biomarker for combination treatment strategies in inflammatory breast cancer
por: Alexander, Angela, et al.
Publicado: (2017) -
PKC iota promotes ovarian tumor progression through deregulation of cyclin E
por: Nanos-Webb, Angela, et al.
Publicado: (2015) -
CDK4/6 and autophagy inhibitors synergistically induce senescence in Rb positive cytoplasmic cyclin E negative cancers
por: Vijayaraghavan, Smruthi, et al.
Publicado: (2017) -
Low-molecular-weight cyclin E: the missing link between biology and clinical outcome
por: Akli, Said, et al.
Publicado: (2004) -
Elafin is downregulated during breast and ovarian tumorigenesis but its residual expression predicts recurrence
por: Caruso, Joseph A, et al.
Publicado: (2014)